4 Einträge gefunden

1. Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy

   1. Laukhtina, Ekaterina
   2. Quhal, Fahad
   3. Mori, Keiichiro
   4. Sari Motlagh, Reza
   5. Rajwa, Pawel
   6. Yanagisawa, Takafumi
   7. Mostafaei, Hadi

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
2. Comparison of Clinicopathologic and Oncological Outcomes Between Transurethral En Bloc Resection and Conventional Transurethral Resection of Bladder Tumor: A Systematic Review, Meta-Analysis and Network Meta-Analysis with Focus on Different Energy Sources

   1. Sari Motlagh, Reza
   2. Rajwa, Pawel
   3. Mori, Keiichiro
   4. Laukhtina, Ekaterina
   5. Aydh, Abdulmajeed
   6. Katayama, Satoshi
   7. Yanagisawa, Takafumi

   2022 - Forschungsinformationssystem des UKE
3. Reassessment of the Efficacy of Carboplatin for Metastatic Urothelial Carcinoma in the Era of Immunotherapy: A Systematic Review and Meta-analysis

   1. Mori, Keiichiro
   2. Schuettfort, Victor M
   3. Yanagisawa, Takafumi
   4. Katayama, Satoshi
   5. Pradere, Benjamin
   6. Laukhtina, Ekaterina
   7. Rajwa, Pawel

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomes

   1. Laukhtina, Ekaterina
   2. Sari Motlagh, Reza
   3. Mori, Keiichiro
   4. Katayama, Satoshi
   5. Rajwa, Pawel
   6. Yanagisawa, Takafumi
   7. Quhal, Fahad

   2021 - Forschungsinformationssystem des UKE - frei zugänglich